FLOMAX
LOE ApproachingNDAORALCAPSULE
Approved
Apr 1997
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
7
Data completeness
5/8 — Partial
FLOMAX by Sanofi is (bph) are related to bladder outlet obstruction, which is comprised of two underlying components: static and dynamic. Approved for the signs, symptoms of benign prostatic hyperplasia (bph) [see ], hypertension. First approved in 1997.
Drug data last refreshed 16h ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
FLOMAX (tamsulosin) is an oral alpha-1A adrenoceptor antagonist approved in 1997 for benign prostatic hyperplasia (BPH). It selectively blocks alpha-1A receptors (70% of prostate alpha-1 receptors) to relax smooth muscle in the prostate and bladder neck, improving urine flow and reducing BPH symptoms. The drug is not indicated for hypertension despite some competitive overlap in the market.
$0.002BPart D
LOE ApproachingDeclining
As LOE approaches, the FLOMAX brand team will contract significantly; remaining roles will focus on defensive generics strategy and market share preservation among loyal prescribers rather than growth.
Mechanism of Action
(BPH) are related to bladder outlet obstruction, which is comprised of two underlying components: static and dynamic. The static component is related to an increase in prostate size caused, in part, by a proliferation of smooth muscle cells in the prostatic stroma. However, the severity of BPH…
Indications (2)
Worked on FLOMAX at Sanofi? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.